Atypical Kinase RIOK2 Is a Master Regulator of Hematopoietic Cell Fate

干细胞 生物 造血 祖细胞 髓样 骨髓增生异常综合症 免疫学 造血干细胞 骨髓生成 川地34 骨髓衰竭 红细胞生成 癌症研究 骨髓 医学 贫血 内科学 细胞生物学
作者
Shrestha Ghosh,Mahesh Raundhal,Samuel A. Myers,Steven A. Carr,Xi Chen,Gregory A. Petsko,Laurie H. Glimcher
出处
期刊:Blood [Elsevier BV]
卷期号:138 (Supplement 1): 300-300
标识
DOI:10.1182/blood-2021-149779
摘要

Abstract Here we report the discovery of a new master regulator of cell fate during hematopoietic differentiation, one whose function has major implications for the treatment of blood disorders such as anemia. Anemia is a major comorbidity in aging, chronic diseases such as renal failure and inflammation, bone marrow failure disorders and in hematologic neoplasms such as myelodysplastic syndromes (MDS), affecting roughly one third of the world population. Anemia is also often diagnosed in patients treated with chemotherapy or other cytotoxic agents. The comorbidities of peripheral blood cytopenias especially in elderly patients with MDS often outweigh the treatment benefits from allogeneic stem cell transplants leaving only a handful of FDA-approved drugs/therapies for treatment of such disorders. There is thus a dire need to revisit the origins of hematopoietic differentiation defects underlying these hematologic disorders to identify additional targets for novel therapies in treating anemia. We present evidence establishing that right open reading frame kinase 2 (RIOK2), an understudied atypical kinase associated with pre-40S ribosome biogenesis (Ferreira-Cerca et al., Nat. Str. Biol. 2012), is also a master transcriptional regulator of hematopoietic lineage commitment that simultaneously drives erythroid differentiation and represses myeloid and megakaryocytic lineages. We show that ablation of RIOK2 expression leads to hematopoietic differentiation defects in primary human hematopoietic stem and progenitor cells, the cells of origin for hematologic neoplasms. We identity RIOK2 as an integral player in governing major blood cell differentiation processes: erythropoiesis, megakaryopoiesis and myelopoiesis. Analyses in primary human CD34+ hematopoietic stem and progenitor cells (HSPCs) revealed that CRISPR/Cas9-mediated depletion of RIOK2 led to impaired erythropoiesis and a concomitant elevation in megakaryopoiesis and myelopoiesis. A more comprehensive analysis revealed that RIOK2 regulates the transcriptomic profiles of several key transcription factors that determine hematopoietic cell fate, including GATA1, GATA2, SPI1, RUNX3 and KLF1. Most importantly, we also observed a significant correlation between mRNA levels of RIOK2 and GATA1, GATA2, RUNX3 and KLF1 in MDS patient-derived bone marrow cells. We also demonstrate that loss of RIOK2 causes massive alterations in chromatin accessibility, both globally and specifically at the promoters of its putative target genes. This places RIOK2 at the apex of a transcriptional regulatory network controlling hematopoietic differentiation. We identify a previously unappreciated DNA-binding winged helix-turn-helix (wHTH) domain in RIOK2 conferring the protein with the properties and activities of a transcription factor. Transcriptomic profiling, structural modeling, chromatin immunoprecipitation-sequencing and a range of domain-deleted mutants reveal that RIOK2 functions as a bona-fide master transcription factor in hematopoiesis. We also identify two transactivation domains within the wHTH motif of RIOK2 that play integral roles in associating with the core transcriptional complex at promoter regions of genes. To the best of our knowledge, we present the first evidence of a protein that not only controls 40S ribosome biogenesis governing translation but also functions in the nucleus as a master transcription factor by regulating the expression of key transcription factors that determine hematopoietic cell fate. Our discovery of a novel master transcriptional regulator governing a multitude of hematopoietic lineages significantly advances our current understanding of the transcriptomic landscape underlying hematopoietic differentiation. We hope that our findings may lead to new approaches to target these newly identified regulatory networks in hematopoiesis that may be relevant not just for malignancies, but for other hematologic disorders as well, such as the anemia of aging, chronic and inflammatory diseases and aplastic anemias. We are hopeful that this study will also lay a foundation to discovering how proteins, like RIOK2, may integrate transcriptional processes with translational outcomes to drive cellular functions. Disclosures Raundhal: Jnana Therapeutics: Current Employment. Petsko: Amicus Therapeutics, MeiraGTx, Annovis Bio, Retromer Therapeutics, and Proclara Bioscience: Membership on an entity's Board of Directors or advisory committees; Denali Therapeutics, MeiraGTx, Annovis Bio, Retromer Therapeutics and Proclara Biosciences: Current equity holder in publicly-traded company. Glimcher: Kaleido Therapeutics: Membership on an entity's Board of Directors or advisory committees; Bristol Myers Squibb: Other: Former Director; Repare Therapeutics: Membership on an entity's Board of Directors or advisory committees; GlaxoSmithKline: Membership on an entity's Board of Directors or advisory committees; Abpro Therapeutics: Membership on an entity's Board of Directors or advisory committees.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
xinjie发布了新的文献求助10
刚刚
2秒前
蛋花肉圆汤完成签到,获得积分10
2秒前
羞涩的文轩完成签到 ,获得积分10
3秒前
8秒前
9秒前
北城完成签到 ,获得积分10
11秒前
量子星尘发布了新的文献求助10
11秒前
14秒前
爱听歌电灯胆完成签到 ,获得积分10
14秒前
不爱吃西葫芦完成签到 ,获得积分10
15秒前
申燕婷完成签到 ,获得积分10
16秒前
橙子完成签到 ,获得积分10
18秒前
ruochenzu发布了新的文献求助10
18秒前
fusheng完成签到 ,获得积分10
27秒前
浮生完成签到 ,获得积分10
32秒前
xinjie完成签到,获得积分10
34秒前
Will完成签到,获得积分10
39秒前
cuddly完成签到 ,获得积分10
40秒前
掉头发的小白完成签到,获得积分10
41秒前
不想看文献完成签到 ,获得积分10
44秒前
45秒前
当女遇到乔完成签到 ,获得积分10
45秒前
独行者完成签到,获得积分10
46秒前
眼睛大的电脑完成签到,获得积分10
46秒前
48秒前
敏敏发布了新的文献求助10
49秒前
木木完成签到 ,获得积分10
50秒前
量子星尘发布了新的文献求助10
50秒前
JamesPei应助科研通管家采纳,获得10
51秒前
彭于晏应助科研通管家采纳,获得10
51秒前
如意2023完成签到 ,获得积分10
51秒前
fomo完成签到,获得积分10
55秒前
nagi发布了新的文献求助10
58秒前
jfeng完成签到,获得积分10
1分钟前
JN完成签到,获得积分10
1分钟前
忐忑的书桃完成签到 ,获得积分10
1分钟前
qaplay完成签到 ,获得积分0
1分钟前
友好语风完成签到,获得积分10
1分钟前
CLTTTt完成签到,获得积分10
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038066
求助须知:如何正确求助?哪些是违规求助? 3575779
关于积分的说明 11373801
捐赠科研通 3305584
什么是DOI,文献DOI怎么找? 1819239
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022